Annual EBIT
-$44.59 M
+$1.90 M+4.08%
December 31, 2023
Summary
- As of February 27, 2025, TBIO annual earnings before interest & taxes is -$44.59 million, with the most recent change of +$1.90 million (+4.08%) on December 31, 2023.
- During the last 3 years, TBIO annual EBIT has fallen by -$37.85 million (-561.65%).
- TBIO annual EBIT is now -561.65% below its all-time high of -$6.74 million, reached on December 1, 2020.
Performance
TBIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$11.35 M
-$2.93 M-34.78%
June 30, 2024
Summary
- As of February 27, 2025, TBIO quarterly earnings before interest & taxes is -$11.35 million, with the most recent change of -$2.93 million (-34.78%) on June 30, 2024.
- Over the past year, TBIO quarterly EBIT has stayed the same.
- TBIO quarterly EBIT is now -136.67% below its all-time high of $30.94 million, reached on September 1, 2020.
Performance
TBIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$45.54 M
-$4.29 M-10.41%
June 30, 2024
Summary
- As of February 27, 2025, TBIO TTM earnings before interest & taxes is -$45.54 million, with the most recent change of -$4.29 million (-10.41%) on June 30, 2024.
- Over the past year, TBIO TTM EBIT has stayed the same.
- TBIO TTM EBIT is now -209.26% below its all-time high of $41.68 million, reached on June 1, 2021.
Performance
TBIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TBIO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.1% | 0.0% | 0.0% |
| 3 y3 years | -561.6% | -156.0% | -209.3% |
| 5 y5 years | +43.7% | +51.3% | +53.1% |
TBIO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.7% | +4.1% | -156.0% | +28.4% | -209.3% | at low |
| 5 y | 5-year | -561.6% | +54.1% | -136.7% | +60.2% | -209.3% | +54.0% |
| alltime | all time | -561.6% | +54.1% | -136.7% | +60.2% | -209.3% | +54.0% |
Telesis Bio EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$11.35 M(+34.8%) | -$45.54 M(+10.4%) |
| Mar 2024 | - | -$8.42 M(-46.9%) | -$41.25 M(-5.6%) |
| Dec 2023 | -$44.59 M(-4.1%) | -$15.84 M(+59.5%) | -$43.70 M(+22.3%) |
| Sep 2023 | - | -$9.93 M(+40.9%) | -$35.72 M(-5.4%) |
| Jun 2023 | - | -$7.05 M(-35.1%) | -$37.77 M(-16.5%) |
| Mar 2023 | - | -$10.87 M(+38.2%) | -$45.24 M(+31.6%) |
| Dec 2022 | -$46.49 M(+23.7%) | -$7.86 M(-34.4%) | -$34.38 M(+29.7%) |
| Sep 2022 | - | -$11.99 M(-17.5%) | -$26.52 M(+82.5%) |
| Jun 2022 | - | -$14.53 M(-171.7%) | -$14.53 M(-134.9%) |
| Dec 2021 | -$37.58 M(+457.5%) | - | - |
| Jun 2021 | - | $20.25 M(-216.7%) | $41.68 M(>+9900.0%) |
| Mar 2021 | - | -$17.36 M(-321.2%) | $146.00 K(-102.2%) |
| Dec 2020 | -$6.74 M | $7.85 M(-74.6%) | -$6.74 M(-84.4%) |
| Sep 2020 | - | $30.94 M(-245.4%) | -$43.07 M(-55.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$21.28 M(-12.2%) | -$96.92 M(-2.0%) |
| Mar 2020 | - | -$24.24 M(-14.9%) | -$98.94 M(+1.8%) |
| Dec 2019 | -$97.20 M(+22.7%) | -$28.48 M(+24.3%) | -$97.20 M(+7.3%) |
| Sep 2019 | - | -$22.91 M(-1.7%) | -$90.58 M(+4.9%) |
| Jun 2019 | - | -$23.30 M(+3.5%) | -$86.32 M(+2.5%) |
| Mar 2019 | - | -$22.50 M(+2.9%) | -$84.23 M(+6.3%) |
| Dec 2018 | -$79.21 M(+29.1%) | -$21.87 M(+17.2%) | -$79.21 M(+6.0%) |
| Sep 2018 | - | -$18.65 M(-12.1%) | -$74.75 M(+5.6%) |
| Jun 2018 | - | -$21.21 M(+21.3%) | -$70.80 M(+6.9%) |
| Mar 2018 | - | -$17.48 M(+0.4%) | -$66.22 M(+8.0%) |
| Dec 2017 | -$61.33 M(+128.8%) | -$17.40 M(+18.4%) | -$61.33 M(+39.6%) |
| Sep 2017 | - | -$14.70 M(-11.6%) | -$43.93 M(+50.3%) |
| Jun 2017 | - | -$16.63 M(+32.1%) | -$29.23 M(+132.1%) |
| Mar 2017 | - | -$12.59 M | -$12.59 M |
| Dec 2016 | -$26.80 M | - | - |
FAQ
- What is Telesis Bio annual earnings before interest & taxes?
- What is the all time high annual EBIT for Telesis Bio?
- What is Telesis Bio annual EBIT year-on-year change?
- What is Telesis Bio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Telesis Bio?
- What is Telesis Bio quarterly EBIT year-on-year change?
- What is Telesis Bio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Telesis Bio?
- What is Telesis Bio TTM EBIT year-on-year change?
What is Telesis Bio annual earnings before interest & taxes?
The current annual EBIT of TBIO is -$44.59 M
What is the all time high annual EBIT for Telesis Bio?
Telesis Bio all-time high annual earnings before interest & taxes is -$6.74 M
What is Telesis Bio annual EBIT year-on-year change?
Over the past year, TBIO annual earnings before interest & taxes has changed by +$1.90 M (+4.08%)
What is Telesis Bio quarterly earnings before interest & taxes?
The current quarterly EBIT of TBIO is -$11.35 M
What is the all time high quarterly EBIT for Telesis Bio?
Telesis Bio all-time high quarterly earnings before interest & taxes is $30.94 M
What is Telesis Bio quarterly EBIT year-on-year change?
Over the past year, TBIO quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Telesis Bio TTM earnings before interest & taxes?
The current TTM EBIT of TBIO is -$45.54 M
What is the all time high TTM EBIT for Telesis Bio?
Telesis Bio all-time high TTM earnings before interest & taxes is $41.68 M
What is Telesis Bio TTM EBIT year-on-year change?
Over the past year, TBIO TTM earnings before interest & taxes has changed by $0.00 (0.00%)